Certification acknowledges care of dying patients
The American Board of Radiology now offers a certificate in hospice and palliative care, designed for doctors whose work involves the care of seriously ill and dying patients.
The American Board of Radiology now offers a certificate in hospice and palliative care, designed for doctors whose work involves the care of seriously ill and dying patients.
Hospice practices and palliative medicine are based on expanding scientific knowledge about symptom control when cure is not available and appropriate end-of-life care is the goal. Though the certification is not intended to confer privilege to practice, the recognition could offer an advantage for physicians who choose to specialize in that area, said Dr. Bruce Haffty, an ABR radiation oncology trustee.
"Radiation oncologists, as part of our practice, routinely care for patients who are terminally ill or require palliation of their disease," Haffty said.
He noted that diagnostic radiologists would be less interested but could see some involvement.
"There are some who might specialize in procedures that are often used with patients in that category, such as interventional radiologists," he said.
The subspecialty is available to all ABR-certified radiologists. Doctors must do at least 100 hours on a hospice and palliative care team and be involved in the care of at least 50 terminally ill patients over a two-year period, Haffty said.
The final step is an examination, which will be administered this October. The certification is good for 10 years.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
